 | Up a level |
Gerber, Tiemo S; Ridder, Dirk A; Goeppert, Benjamin; Brobeil, Alexander; Stenzel, Philipp; Zimmer, Stefanie; Jäkel, Jörg; Metzig, Marie Oliver; Schwab, Roxana; Martin, Steve Z; Kiss, András; Bergmann, Frank; Schirmacher, Peter; Galle, Peter R; Lang, Hauke; Roth, Wilfried; Straub, Beate K (2024). N-cadherin: A diagnostic marker to help discriminate primary liver carcinomas from extrahepatic carcinomas. International journal of cancer, 154(10), pp. 1857-1868. Wiley 10.1002/ijc.34836
Haber, Philipp K; Castet, Florian; Torres-Martin, Miguel; Andreu-Oller, Carmen; Puigvehí, Marc; Maeda, Miho; Radu, Pompilia; Dufour, Jean-Francois; Verslype, Chris; Czauderna, Carolin; Marquardt, Jens U; Galle, Peter R; Vogel, Arndt; Bathon, Melanie; Meyer, Tim; Labgaa, Ismail; Digklia, Antonia; Roberts, Lewis R; Mohamed Ali, Mohamed A; Mínguez, Beatriz; ... (2023). Molecular markers of response to anti-PD1 therapy in advanced hepatocellular carcinoma. Gastroenterology, 164(1), 72-88.e18. Elsevier 10.1053/j.gastro.2022.09.005
Galle, Peter R; Kudo, Masatoshi; Llovet, Josep M; Finn, Richard S; Karwal, Mark; Pezet, Denis; Kim, Tae-You; Yang, Tsai-Sheng; Lonardi, Sara; Tomasek, Jiri; Phelip, Jean-Marc; Touchefeu, Yann; Koh, Su-Jin; Stirnimann, Guido; Liang, Kun; Ogburn, Kenyon D; Wang, Chunxiao; Abada, Paolo; Widau, Ryan C and Zhu, Andrew X (2021). Ramucirumab in patients with previously treated advanced hepatocellular carcinoma: Impact of liver disease aetiology. Liver international, 41(11), pp. 2759-2767. Wiley 10.1111/liv.14994
Muñoz-Martínez, Sergio; Sapena, Victor; Forner, Alejandro; Nault, Jean-Charles; Sapisochin, Gonzalo; Rimassa, Lorenza; Sangro, Bruno; Bruix, Jordi; Sanduzzi-Zamparelli, Marco; Hołówko, Wacław; El Kassas, Mohamed; Mocan, Tudor; Bouattour, Mohamed; Merle, Philippe; Hoogwater, Frederik J H; Alqahtani, Saleh A; Reeves, Helen L; Pinato, David J; Giorgakis, Emmanouil; Meyer, Tim; ... (2021). Assessing the impact of COVID-19 on liver cancer management (CERO-19). JHEP reports, 3(3), p. 100260. Elsevier 10.1016/j.jhepr.2021.100260
Gerbes, Alexander; Zoulim, Fabien; Tilg, Herbert; Dufour, Jean-François; Bruix, Jordi; Paradis, Valérie; Salem, Riad; Peck-Radosavljevic, Markus; Galle, Peter R; Greten, Tim F; Nault, Jean-Charles; Avila, Matias A (2018). Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma. Gut, 67(2), pp. 380-388. BMJ Publishing Group 10.1136/gutjnl-2017-315068
Bolondi, Luigi; Burroughs, Andrew; Dufour, Jean-François; Galle, Peter R; Mazzaferro, Vincenzo; Piscaglia, Fabio; Raoul, Jean Luc; Sangro, Bruno (2012). Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions. Seminars in liver disease, 32(4), pp. 348-59. New York, N.Y.: Thieme Medical Publishers 10.1055/s-0032-1329906
Mudter, Jonas; Yu, Jingling; Zufferey, Christel; Brüstle, Anne; Wirtz, Stefan; Weigmann, Benno; Hoffman, Arthur; Schenk, Mirjam; Galle, Peter R; Lehr, Hans A; Mueller, Christoph; Lohoff, Michael; Neurath, Markus F (2011). IRF4 regulates IL-17A promoter activity and controls RORγt-dependent Th17 colitis in vivo. Inflammatory bowel diseases, 17(6), pp. 1343-1358. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1002/ibd.21476
Mudter, Jonas; Amoussina, Lioubov; Schenk, Mirjam; Yu, Jingling; Brüstle, Anne; Weigmann, Benno; Atreya, Raja; Wirtz, Stefan; Becker, Christoph; Hoffman, Arthur; Atreya, Imke; Biesterfeld, Stefan; Galle, Peter R; Lehr, Hans A; Rose-John, Stefan; Mueller, Christoph; Lohoff, Michael; Neurath, Markus F (2008). The transcription factor IFN regulatory factor-4 controls experimental colitis in mice via T cell-derived IL-6. Journal of clinical investigation, 118(7), pp. 2415-26. Ann Arbor, Mich.: American Society for Clinical Investigation 10.1172/JCI33227
